InMed Pharmaceuticals Inc. (INM) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.76M | -3.23M | -2.24M | -1.78M | -1.66M | -2.5M | -1.83M | -1.03M | -1.93M | -1.82M | -2.17M | -736.68K |
| Operating CF Margin % | -0.27% | -286.73% | -200.17% | -100.08% | -131.54% | -225.07% | -144.45% | -80.21% | -164.96% | -146.53% | -241.08% | -24.06% |
| Operating CF Growth % | -6% | -28.96% | -22.74% | -72.81% | 14.21% | -37.69% | 15.98% | -39.7% | -16.9% | 33.02% | 3.61% | 81.53% |
| Net Income | -2.79M | -3.75B | -2.41M | -1.79M | -2.12M | -2.58M | -1.68M | -1.94M | -1.72M | -1.48M | -2.54M | -338.39K |
| Depreciation & Amortization | 134.66K | 314.54M | 218.53K | 131.08K | 129.58K | 129.08K | 144.98K | 151.86K | 150.69K | 148.32K | 149.36K | 150.13K |
| Stock-Based Compensation | 0 | 45.45M | 20.2K | 26.73K | 40.45K | 23.16K | 28.96K | 38.95K | 55.3K | 0 | 25.19K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 94.95K | 0 |
| Other Non-Cash Items | -244.87K | 3.39B | 1.89K | 32.88K | 25.98K | 14.71K | 4.75K | 52.08K | 1.38K | 217.66K | -538 | -394.61K |
| Working Capital Changes | 1.14M | -821.01K | -82.23K | -180.88K | 265.42K | -94.06K | -327.64K | 665.61K | -418.82K | -705.04K | 93.65K | -153.81K |
| Change in Receivables | 0 | 217.12K | 170.38K | -99.72K | -105.24K | 22.13K | 68.14K | -145.16K | 165.19K | -206.16K | 94.55K | -112.8K |
| Change in Inventory | 0 | -173.91K | 98.14K | -147.2K | 289.39K | 116.72K | 24.25K | -92.78K | -449.11K | 213.12K | 390.33K | -11.45K |
| Change in Payables | 110.28K | -77.25K | -382.25K | 0 | 0 | 0 | 0 | 0 | 0 | 243.84K | -375.06K | -227.72K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88 | -2 | -9.22K | 0 | -41.15K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88 | -2 | -9.22K | 0 | -159.6K |
| CapEx % of Revenue | 0% | 0% | - | - | - | - | - | 0.01% | 0% | 0.74% | - | 5.21% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 118.45K |
| Cash from Financing | 231.48K | 1.16K | -191.33K | 8.17M | 2.92M | 338.52K | 838.24K | 176 | 0 | 4.62M | 0 | 129.7K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 231.48K | 1.16K | -191.33K | 3.77M | 2.94M | 396.15K | 1.03M | -43.83K | 0 | 4.62M | 0 | 129.7K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 4.41M | -15.1K | -57.63K | -191.82K | 44K | 0 | 0 | 0 | 0 |
| Net Change in Cash | -1.8M | -3.26M | -2.43M | 6.4M | 1.26M | -2.16M | -988.57K | -1.03M | -1.93M | 2.8M | -2.17M | -691.54K |
| Free Cash Flow | -1.76M | -3.23M | -2.24M | -1.78M | -1.66M | -2.5M | -1.83M | -1.03M | -1.93M | -1.83M | -2.17M | -896.29K |
| FCF Margin % | -0.27% | -286.73% | -200.17% | -100.08% | -131.54% | -225.07% | -144.45% | -80.21% | -164.96% | -147.27% | -241.08% | -29.28% |
| FCF Growth % | -5.99% | -28.96% | -22.74% | -72.81% | 14.21% | -36.99% | 15.98% | -14.82% | -16.9% | 32.68% | 3.61% | 77.53% |
| FCF per Share | -0.43 | -816.10 | -567.07 | -0.89 | -1.51 | -3.54 | -2.95 | -2.31 | -4.02 | -4.58 | -13.07 | -5.39 |
| FCF Conversion (FCF/Net Income) | 0.59x | 1.16x | 1.30x | 0.73x | 0.78x | 0.97x | 1.09x | 0.53x | 1.12x | 1.23x | 0.86x | 1.64x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.1K | 0 | 0 | 0 | 0 |